Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by KayakerBCon Sep 16, 2016 10:59am
142 Views
Post# 25244760

RE:RE:Regardless - the idiot

RE:RE:Regardless - the idiotOilpatch, on June 9th you said "i liquidated 50% of my position since monday...decent 45% gain".

Looking at the share price on those dates (June 6-9), you must have sold for at least 1.35.  Getting a 45% gain means the average cost on your initial position was at least 93¢.  

On June 10th you said you had 50,000 shares left.

Yesterday you said you bought back 50,000 - 6,450 = 43,550 shares and paid a higher price for them....

"....but i paid the premium and have everything back that i sold except for around [6450] shares....i was going to buy them but it moved fast to the 1.60$ range the next week so i didn't...."

So you bought back the shares somewhere north of 1.60.

And yesterday you said "the best part about it all is that my average is 1.05$"

How do you combine 50,000 shares at a cost of 93¢ with 43,550 shares at a cost north of 1.60 and get an average of 1.05?


Bullboard Posts